|
|
|
|
LEADER |
02442nam a2200325Ia 4500 |
001 |
10.3390-biomedicines10050967 |
008 |
220706s2022 CNT 000 0 und d |
020 |
|
|
|a 22279059 (ISSN)
|
245 |
1 |
0 |
|a Arsenic Activates the ER Stress-Associated Unfolded Protein Response via the Activating Transcription Factor 6 in Human Bronchial Epithelial Cells
|
260 |
|
0 |
|b MDPI
|c 2022
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.3390/biomedicines10050967
|
520 |
3 |
|
|a Arsenic is a well-known human carcinogen associated with a number of cancers, including lung cancers. We have previously shown that long-term exposure to an environmentally relevant concentration of inorganic arsenic (As3+) leads to the malignant transformation of the BEAS2B cells, and some of the transformed cells show cancer stem-like features (CSCs) with a significant upregulation of glycolysis and downregulation of mitochondrial oxidative phosphorylation. In the present report, we investigate the short-term effect of As3+ on the endoplasmic reticulum (ER) stress response—the “unfolded protein response (UPR)” and metabolism in human bronchial epithelial cell line BEAS-2B cells. Treatment of the cells with inorganic As3+ upregulated both glycolysis and mitochondrial respiration. Analysis of ER UPR signaling pathway using a real-time human UPR array revealed that As3+ induced a significant up-regulation of some UPR genes, including ATF6, CEBPB, MAPK10, Hsp70, and UBE2G2. Additional tests confirmed that the induction of ATF6, ATF6B and UBE2G2 mRNAs and/or proteins by As3+ is dose dependent. Chromosome immunoprecipitation and global sequencing indicated a critical role of Nrf2 in mediating As3+-induced expression of these UPR genes. In summary, our data suggest that As3+ is able to regulate the ER stress response, possibly through activating the ATF6 signaling. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
|
650 |
0 |
4 |
|a arsenic
|
650 |
0 |
4 |
|a ATF6
|
650 |
0 |
4 |
|a ER stress
|
650 |
0 |
4 |
|a metabolism
|
650 |
0 |
4 |
|a Nrf2
|
650 |
0 |
4 |
|a UPR
|
700 |
1 |
0 |
|a Almutairy, B.
|e author
|
700 |
1 |
0 |
|a Bi, Z.
|e author
|
700 |
1 |
0 |
|a Chen, F.
|e author
|
700 |
1 |
0 |
|a Fu, Y.
|e author
|
700 |
1 |
0 |
|a Hüttemann, M.
|e author
|
700 |
1 |
0 |
|a Qiu, Y.
|e author
|
700 |
1 |
0 |
|a Thakur, C.
|e author
|
700 |
1 |
0 |
|a Wadgaonkar, P.
|e author
|
700 |
1 |
0 |
|a Wan, J.
|e author
|
700 |
1 |
0 |
|a Zhang, Q.
|e author
|
700 |
1 |
0 |
|a Zhang, W.
|e author
|
773 |
|
|
|t Biomedicines
|